Who invested in Arch Oncology?
Arch Oncology's investors include Lightchain, RiverVest, Roche Ventures and 3x5 Partners. Lightchain led its latest round.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2019, from 1 source
Arch Oncology's investors include Lightchain, RiverVest, Roche Ventures and 3x5 Partners. Lightchain led its latest round.
Arch Oncology has raised $50M across 1 round since 2019.
Arch Oncology's most recent round was a Series B of $50M in Mar 2019, led by Lightchain.
Its most recent round, $50M in Mar 2019, is also its largest on record.
Arch Oncology's first round on record, in Mar 2019, was backed by Lightchain, RiverVest and Roche Ventures and 1 others.
Arch Oncology's latest named round is a Series B, in Mar 2019.
Arch Oncology is based in the United States.
Lightchain led the Series B in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.